아시아태평양의 PCR 기술 시장 예측(-2030년) : 지역별 분석 - 기술별, 제품별, 용도별, 최종사용자별

The Asia Pacific PCR technologies market is expected to grow from US$ 2,835.20 million in 2022 to US$ 5,465.60 million by 2030. It is estimated to record a CAGR of 8.6% from 2022 to 2030.

Surging Investments and Funds Availability for PCR Technologies Boost Asia Pacific PCR Technologies Market

Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research in 2023, Mirxes, a leading innovator in RNA technology, specializes in accurate, non-invasive, and reasonably priced blood-based miRNA testing kits for early disease detection, particularly cancer, raised US $50 million in a Series D funding round. The company's main offering, GASTROClear, is an in vitro diagnostic test that uses PCR to detect stomach cancer early on. It has been designated as a Breakthrough Device by the US FDA. This is the first time that the US FDA has given such a classification to an IVD test for early diagnosis of stomach cancer, a molecular IVD test from Southeast Asia, and a blood miRNA test worldwide. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In In 2022, Temasek contributed US $85 million to the healthtech business Molbio Diagnostics, located in India. Molbio designs portable diagnostic tools for a range of conditions, including HIV, dengue, malaria, hepatitis, and tuberculosis (TB). In 2021, in a Series E+ fundraising round, Ustar, a Chinese point-of-care (POC) business that creates molecular diagnostic tools, raised roughly US$ 2.6 million. Ustar will use a portion of the funds raised to improve the effectiveness of their flagship high-throughput, completely automated nucleic acid amplification test instrument. The remaining funds will go into developing a next generation testing platform, increasing the variety of tests offered, and mass-producing polymerase chain reaction (PCR) testing kits for home usage.

Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.

Asia Pacific PCR Technologies Market Overview

The Asia Pacific PCR technologies market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in Asia Pacific is mainly attributed to the increasing foreign direct investments; the large availability of highly skilled, efficient workforces; and streamlining government policies resulting in high investments in the biotechnology sector. In addition, increasing cases of infectious and chronic diseases, and government and non-government initiatives fuel the growth of the PCR technologies market in Asia Pacific. The projected growth of the PCR technologies market in China during the forecast period is attributed to the increasing demand for high-quality healthcare products, growing prevalence of lifestyle diseases in the country, rising developments in diagnostics technologies, surging number of diagnostic centers and hospitals, and the ongoing modernization of medical facilities in hospitals. In China, PCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT). According to the article "Rare Disease Day: why China's Rare Disease Burden Could Be an Opportunity for Innovation," published in February 2023, ~20 million Chinese people suffer from rare diseases. PCR techniques such as dPCR and qPCR can be used in the diagnosis and treatment (to monitor treatment response) of such rare conditions. The rising prevalence of cancer in China also contributes to the PCR technologies market growth. According to the Global Cancer Observatory data, ~4.6 million cancer cases were reported in the country in 2020. In addition, cancer resulted in the death of 3.1 million people in China. China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) In terms of value, the PCR technologies market in China was valued at US$ 776.23 million in 2022 and is projected to reach US$ 1,545.21 million by 2030; it is expected to register a CAGR of 9.00% during the forecast period.

Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific PCR Technologies Market Segmentation

The Asia Pacific PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held largest share of Asia Pacific PCR technologies market in 2022.

In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Asia Pacific PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Asia Pacific PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Asia Pacific PCR technologies market in 2022.

Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of Asia Pacific PCR technologies market in 2022.

By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Asia Pacific PCR technologies market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific PCR Technologies Market - Key Industry Dynamics

• 4.1 PCR Technologies Market - Key Industry Dynamics
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
  • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
• 4.3 Market Restraints
  • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
• 4.4 Market Opportunities
  • 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
  • 4.4.2 Increasing Demand for POC Testing
• 4.5 Future Trends
  • 4.5.1 Advancements in PCR Technologies
• 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Asia Pacific Market Analysis

• 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Asia Pacific PCR Technologies Market Analysis - By Technology

• 6.1 Overview
• 6.2 Real Time PCR
  • 6.2.1 Overview
  • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.3 Conventional PCR
  • 6.3.1 Overview
  • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.4 Reverse Transcription PCR
  • 6.4.1 Overview
  • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.5 Digital PCR
  • 6.5.1 Overview
  • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.6 Multiplex RT PCR
  • 6.6.1 Overview
  • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.7 Hot Start PCR
  • 6.7.1 Overview
  • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.8 Others
  • 6.8.1 Overview
  • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific PCR Technologies Market Analysis - By Offerings

• 7.1 Overview
• 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
• 7.3 Reagents and Consumables
  • 7.3.1 Overview
  • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
    • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
      • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
• 7.4 Instruments
  • 7.4.1 Overview
  • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
    • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
• 7.5 Software and Services
  • 7.5.1 Overview
  • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific PCR Technologies Market Analysis - By Application

• 8.1 Overview
• 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
• 8.3 Gene Expression Analysis
  • 8.3.1 Overview
  • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
• 8.4 Genetic Sequencing
  • 8.4.1 Overview
  • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
• 8.5 Genotyping
  • 8.5.1 Overview
  • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
• 8.6 Nucleic Acid Synthesis
  • 8.6.1 Overview
  • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
• 8.7 Standard Validation
  • 8.7.1 Overview
  • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
• 8.8 Point of Care Diagnostics
  • 8.8.1 Overview
  • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
• 8.9 Environmental Application
  • 8.9.1 Overview
  • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
• 8.10 Others
  • 8.10.1 Overview
  • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific PCR Technologies Market Analysis - By End User

• 9.1 Overview
• 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Hospitals and Diagnostic Centers
  • 9.3.1 Overview
  • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
• 9.4 Academia and Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
• 9.5 Pharmaceutical and Biotechnology Companies
  • 9.5.1 Overview
  • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific PCR Technologies Market -Country Analysis

• 10.1 Asia Pacific: PCR Technologies Market
  • 10.1.1 Overview
  • 10.1.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis - By Country
    • 10.1.2.1 China
      • 10.1.2.1.1 Overview
    • 10.1.2.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.2.1 China PCR Technologies Market Breakdown by Technology
      • 10.1.2.2.2 China PCR Technologies Market Breakdown by Offerings
      • 10.1.2.2.2.1 China PCR Technologies Market Breakdown by Instruments
      • 10.1.2.2.2.2 China PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.2.3 China PCR Technologies Market Breakdown by Application
      • 10.1.2.2.4 China PCR Technologies Market Breakdown by End User
    • 10.1.2.3 Japan
      • 10.1.2.3.1 Overview
    • 10.1.2.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.4.1 Japan PCR Technologies Market Breakdown by Technology
      • 10.1.2.4.2 Japan PCR Technologies Market Breakdown by Offerings
      • 10.1.2.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
      • 10.1.2.4.2.2 Japan PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.4.3 Japan PCR Technologies Market Breakdown by Application
      • 10.1.2.4.4 Japan PCR Technologies Market Breakdown by End User
    • 10.1.2.5 India
      • 10.1.2.5.1 Overview
    • 10.1.2.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.6.1 India PCR Technologies Market Breakdown by Technology
      • 10.1.2.6.2 India PCR Technologies Market Breakdown by Offerings
      • 10.1.2.6.2.1 India PCR Technologies Market Breakdown by Instruments
      • 10.1.2.6.2.2 India PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.6.3 India PCR Technologies Market Breakdown by Application
      • 10.1.2.6.4 India PCR Technologies Market Breakdown by End User
    • 10.1.2.7 Australia
      • 10.1.2.7.1 Overview
    • 10.1.2.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.8.1 Australia PCR Technologies Market Breakdown by Technology
      • 10.1.2.8.2 Australia PCR Technologies Market Breakdown by Offerings
      • 10.1.2.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
      • 10.1.2.8.2.2 Australia PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.8.3 Australia PCR Technologies Market Breakdown by Application
      • 10.1.2.8.4 Australia PCR Technologies Market Breakdown by End User
    • 10.1.2.9 South Korea
      • 10.1.2.9.1 Overview
    • 10.1.2.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.10.1 South Korea PCR Technologies Market Breakdown by Technology
      • 10.1.2.10.2 South Korea PCR Technologies Market Breakdown by Offerings
      • 10.1.2.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
      • 10.1.2.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.10.3 South Korea PCR Technologies Market Breakdown by Application
      • 10.1.2.10.4 South Korea PCR Technologies Market Breakdown by End User
    • 10.1.2.11 Rest of Asia Pacific
      • 10.1.2.11.1 Overview
    • 10.1.2.12 Rest of Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.12.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Technology
      • 10.1.2.12.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Offerings
      • 10.1.2.12.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Instruments
      • 10.1.2.12.2.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.12.2.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.12.3 Rest of Asia Pacific PCR Technologies Market Breakdown by Application
      • 10.1.2.12.4 Rest of Asia Pacific PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the PCR Technologies Market
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Thermo Fisher Scientific Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Promega Corp
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 QIAGEN NV
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 bioMerieux SA
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Hoffmann-La Roche Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Bio-Rad Laboratories Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Becton Dickinson and Co
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Takara Bio Inc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Standard Biotools Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Agilent Technologies Inc
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
• 12.11 Ellume Ltd
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments

13. Appendix

• 13.1 About the Insight Partners
• 13.2 Glossary of Terms